What Vor Biopharma Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 20 |
| Total trades | 2 | 25 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,000 | 2,102,000 |
| Disposed | 0 | 1,488,571 |
| Net activity | +2,000 | +613,429 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ra Capital MANAGEMENT, L.p. | 10% owner | Oct 02 | Exercise / conversion · M | +500 | $12.80 | +$6.4K | 500 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Aug 24 | Exercise / conversion · M | +1,500 | $3.74 | +$5.6K | 1,500 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Jul 16 | Open-market sale · S | −213 | $19.75 | −$4.21K | 4,501,882 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Jul 16 | In/At-money Exercise · X | +2,100,000 | $0.00 | +$4.2K | 4,502,095 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 22 | Open-market sale · S | −165,150 | $15.77 | −$2.6M | 2,402,095 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 20 | Open-market sale · S | −171,963 | $15.77 | −$2.71M | 2,567,245 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 17 | Open-market sale · S | −458,411 | $16.28 | −$7.46M | 2,739,208 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 15 | Open-market sale · S | −53,644 | $16.01 | −$859K | 3,197,619 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 14 | Open-market sale · S | −153,735 | $15.97 | −$2.46M | 3,251,263 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 13 | Open-market sale · S | −530,610 | $16.15 | −$8.57M | 3,404,998 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 10 | Open-market sale · S | −828 | $15.75 | −$13K | 3,935,608 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 09 | Open-market sale · S | −135,201 | $16.59 | −$2.24M | 3,936,436 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 08 | Open-market sale · S | −130,862 | $16.91 | −$2.21M | 4,071,637 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 08 | Open-market sale · S | −353,242 | $16.32 | −$5.76M | 4,202,499 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 06 | Open-market sale · S | −6,775 | $18.50 | −$125K | 4,555,741 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 06 | Open-market sale · S | −44,728 | $17.31 | −$774K | 4,562,516 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 06 | Open-market sale · S | −537,754 | $16.51 | −$8.88M | 4,607,244 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 02 | Open-market sale · S | −1,525 | $19.06 | −$29.1K | 5,144,998 |
| Ra Capital MANAGEMENT, L.p. | Director | Apr 02 | Open-market sale · S | −258,475 | $18.23 | −$4.71M | 5,146,523 |
| Ra Capital MANAGEMENT, L.p. | Director | Dec 18 | Grant / award · A | −4,625,346 | $10.81 | −$50M | 5,404,998 |
Loading...